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In the models suggested r cently for antigenic peptides binding in the ~,  ~, groove of MHC class I molecules, the orientation of the peptide has 
been shown uniquely as: the N~C vector of the peptide being parallel to the N~C vector of the ~t~ helix of MHC, Here, v~e demonstrate ~hat 
the reverse orientation of the peptide is equally probable. This hypothesis  supported by molecular modelling calculations a d computer graphic 
analyses on a routine class I MHC molecule H-SK ° and its complexes with a restricted peptide RYLENGKETLQ. Analysis of the complementary 
interactions between the peptid¢ residues and the amino acid side chains lining the MHC groove shows that the binding orientation of the peptide 
may be allele-specific and could depend on the sequence and structure of" the antigenic epitope. 
Major histoeompatibility complex, class I: Antigen presentation; Molecular modelling; Binding orientation; Allele-specific 
1. INTRODUCTION 
T cells reeognise viral protein fragments presented on 
the surfa~ of an infected cell by a class I major histo- 
compatibility complex glyeoprotein (MHC) [1]. It is 
now well established that the association with peptide 
fragments, either endogenously processed or ex- 
ogenously added, enhances the structural stability of the 
MHC class I proteins [2-5]. X-Ray crystallographic 
analysis of the three-dimensional structures of human 
MHC proteins, HLA-A2 [6,7]. HLA-Aw68 [8] and 
HLA-B27 [9] have revealed the presence of additional 
electron density corresponding to one or more peptides 
in the binding groove formed by the cz t, ~z, helices and 
the eight-stranded ,8-sheet of the MHC heavy chain. 
Whereas the rules regarding the putative sequence 
motif'characteristic of naturally processed self-peptides 
by MHC are being understood [10], relatively little has 
been known so far about the structure and/or confor- 
mation as well as the interactions of  these peptides in- 
side the MHC groove. The length and sequence of the 
characteristic motifs were found to be allele-specific 
[11,12]; similarly, one would expect differences in the 
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manner of presentation a d the conformation of the 
peptides by different MHC alleles. However, in the pu- 
tative models recently proposed for peptide-MHC com- 
plexes [9,13,14], the orientation of the peptide inside the 
MHC groove is shown as: the N-terminal to the C- 
terminal direction fN--->C vector) of the peptide is paral- 
lel to the N---~C vector of the cx t helix of MHC (Figs. 1 
and 2A) (this complex will henceforth be referred to as 
complex I). Since binding of the peptide in the reverse 
orientation, where the N~C vector of the peptide is 
antiparallel to the N.-->C vector of the MHC ~j helix 
(Figs. 1 and 2B) (hem;eforth referred to as complex II), 
is also possible, we undertook to study the peptide- 
binding in the MHC groove in both orientations. In this 
paper we mainly address the following questions: (i) in 
which orientation does the peptide in question interact 
better? (ii) why is one orientation more favourable than 
the other? and (iii) can general rules for MHC-peptide 
interactions be formulated? We use here the example of 
the HLA-A2.170-180 peptide restricted to the mouse 
MHC H-2K d. In previous studies, three agretopic 
(Y171, 7"178, L179) and two epitopic (E173, E177) have 
been identified based on cytolytie assays with CTL 
clones restricted to H-2K '~ [ 15,16]. 
2. MATERIALS AND METHODS 
The molecular modelling calculations were performed with the mur- 
Jn¢ MHC, H-SK d and one of its ~'estricted peptide ¢pitopes By. 
LENGKETLQ derived from HLA-A2 and correspond to the region 
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170--180, (peptide residues are in italics to avoid confusion with the 
residues of MHC) following the work of Bouillot et al. [ 17] and Marti- 
non et al. [15]. Since the three-dimensional structure of H-2K ~ is not 
known, it was derived from the known relined crystal structure ~.oor- 
dinates of HLA-A2 [7] (Brookhavcn Protein Data Bank entry 31-ILA 
[18]), on the basis of extensive sequence homology (73% identity in the 
~'t and ~= domains) between the two MHC proteins. The first step 
consisted of incorporating the appropriate amino acid changes corre- 
sponding to H-2K a sequence, and then to remove an]¢ resultant van 
der Waals clashes. The final, working three-dimensional structure was 
obtained by energy minimisation of the modified protein using the 
molecular mechanics program AMBER [19]. An 11 residue pcptide 
was chosen for complexation i stead of the predicted 10.mar for 
HLA-derivcd epitol~s [12] as it is known that longer peptides can also 
bind to MI-IC [15]. The peptide pitope in its conformation deriv~ 
from the crystallographic coordinates of HLA-A2 [6] followed by 
modelling based on ~H NMR data (B. Gopalakrishnan, F. Cornille, 
F. Martinon, N. Morellet, M.C. Founi~-Zaluski and B.P. Roqucs, 
unpublished) was positioned in the ~q. =: groove of H-2K 'j. In this 
orientation the delineated anchor residues Y171 (2nd residue). 7"178 
and L 179 (gth and 10th residues) [ll,12], which ~vere well orient~gl on 
one side of  the peptide backbone, contact he MHC residues on the 
~/-sheet floor of the groove. Van der Waals clashes betw~n the peptide 
atoms and the MHC atoms were manually removed as much as pos- 
sible before nergy minimisation ofthe complexes (both I and II) with 
AMBER. To facilitate the peptide backbone to adapt itself to the 
environment of the H-2K d groove and to avoid getting stuck in a local 
minimum on the interaction surface, a systematic and stepwis¢ ap- 
preach was followed: successive minimisations of the complex of 
H.2K '~ with (i) A YAAAGAATLA, (it) A YLEAGAE'rLA and (iii) the 
actual cpitope R_YLENGK_ETL~ were carried out. Alanine was cho- 
sen for replacement as it is the smallest representative chiral amino 
acid and does not disturb the local secondary atructure of the polypep- 
tide chain [20]. The total space available for the l~ptide inside the 
MHC groove was sampled by rigid.body translations and rotations 
of the peptide; the best representative complexes were chosen for 
analysis on the basis of the total energy of interaction. All the calcula- 
tions (AMBER) were carried out at the CNRS-CiRCE computer 
center at Orsay (France) and graphic visualisations (Biostructure inc.,
Strasbuurg) were performed on a Silicon Graphics IRIS 4D/35 work- 
station. 
3. RESULTS AND DISCUSSION 
The HLA-A2.170-180 peptide interacts favourably 
within the binding groo,/e of H-2K d in both the parallel 
and antiparallel orientations. Fig. 1 shows a detailed 
scheme of nearest neighbour interactions and hydrogen 
bonds between the peptide and various residues of the 
binding groove of H-2K d. The salient features of the two 
complexes are as follows: the total energy of complex 
II was more favourable compared to that of complex I
by about 20 kcal/mole. The peptide bound slightly 
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Fig. 1. The nearest neighbour interaction scheme between the rcaidum of" HLA.A2./70-JS0 prptide and the residues of H-2K d binding groove in 
the complexes I and ii. Horizontal line represents he peptide chain and the vertical lines indicate residues pointing into (below) the pocket or out 
(above) of the pocket. No vertical lines mean that the residues are partially into and out ofthe pocket. Inter-molecular hydrogen bonds are indicated 
by dashed lines. Salt-bridges in H-2K d are indicated by "r. 
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deeper in complex II than in complex I. The delineated 
anchor esidues of the antigenic peptide Y171, T178 and 
L179 are surrounded by hydrophobic residues of the 
H-2K d groove in both complexes, though less efficiently 
in complex I. Thus in complex II the phenolic ring of 
the princips1 anchor esidue I"171 of the peptide stacks 
ideally with F95; Y171 is flanked by F116 as well and 
seems to be participating in the middle of a festoon of 
aromatic residues consisting .of F74, F95, FI 16 and 
Y123 (Fig. 3). In complex I Y171 of the peptide is
situated between Y7 and 1,5 of H-2K d but stacks poorly 
with Y7 (Fig. 2A). The other two anchor esidues 1"178 
and L179 are also surrounded by hydrophobic residues 
in both complexes (Fig. 1). Moreover, the greater stabil- 
isation of complex II when compared with complex I
also comes from additional intermolecular hydrogen 
bonds between peptide and H-2K a molecules. There are 
eight inter-molecular hydrogen bonds in complex II 
compared to only four in complex I (Fig. 1). 
While possessing several general features common to 
both complexes, the peptide in complex II has a more 
well-defined conformation i side the binding groove of 
H.2K". A salt-bridge interaction between the side 
chains of RITO and E173 and four intra-peptide back- 
bone hydrogen bonds: L172 >C=O --- HN< of G175 
(i.-.-)i ÷ 3) and K176 (i--->i ÷ 4), R170 >C=O --- HN< 
N174 ( i4 i+  4) and K!76 >C=O --- HN< 7"178 
(i---~i + 2), suggesting a helicoidal conformation of the 
peptide, were found in both complexes. However, the 
lengths of the hydrogen bonds are longer and hence 
became weaker in complex I. Residues L172-E173- 
NI74-G17~ formed an ideal type III hydrogen bonded 
/J.turn (0,, ~., = -51", -31°; Oh, ~ = -45 °. -53 °) in the 
complex II. This turn has changed its shape slightly in 
complex I (¢~:, ~,  = -45 °, -48°; 03, ~ = -45°, -40°) 
resulting in the loss of the internal hydrogen bond. In 
addition, complex II has a ~,-turn comprising residues 
K176-E177-T178, adjacent to the/J-turn which may be 
imparting structural stability to the peptide. 
The superposition of the two complexes i shown in 
Fig. 4. The peptide in complex 1 is slightly pushed to- 
wards the ~_, helix, whereas it is positioned more or less 
in the middle of the groove in complex II as observed 
in the crystal structure of HLA-B27 complex [9]. The 
orientation of the peptide in complex I. although com- 
parable to that proposed by Maryanski et al. [14] with 
respect to its proximity to the ~., helix, the latter presents 
a different interaction scheme with the Y171 of the pep- 
tide in close proximity to Y155, Y156 and Y159 on the 
cz,. helix. Two arginines, R66 on the a~ helix and R97 
situated in the middle of the ,6-sheet floor seem to 
largely gtaide the positioning of  the peptide in the 
groove. These arginines are involved in salt-bridges 
with their nearest acidic amino acid side chains (E163 
and D70, respectively) in complex II. The R66-EI63 
salt-bridge has been disrupted by R170 of the peptide 
in complex 1, while the R97-D70 salt-bridge was re- 
tained. In both complexes, the peptide residues impli- 
cated in T cell receptor ecognition, namely, E173 and 
El77, project outside the groove in a similar fashion 
ruling out possible distinction between the two orienta- 
tions by T cell receptors. Similar results have been ob- 
tained with the Plasmodium berghei PB-CS 253-260 pep- 
tide binding to H-2K '~ (to be published). 
Concerning the question of whether an antigenic pep- 
tide has a preferred orientation/direction of binding in- 
side the MHC groove, several examples need to be 
analysed experimentally and theoretically before a de- 
finitive answer could be given. For the peptide in the 
present study (HLA-A2.170-180) binding in the groove 
of H-2K '~, there is a preference for the orientation as in 
complex II. The results of Latroa et al. [21] for the 
influenza matrix peptide 57--68 (KGILGFVFTLTV) 
binding in the groove of HLA-A2 support the parallel 
orientation (complex I). However, the orientational/di- 
rectional preference may be allele-specific, implying that 
various antigenic peptides possessing an allele-specific 
sequence motif interact in a particular orientation. The 
directional binding mode may be governed by several 
factors uch as, the amino acid sequence and the confor- 
mational characteristics of the restricted peptide pitope 
as well as the polymorphism of MHC molecules which 
determines the landscape (surface undulation) of the 
binding groove. Since the length of most peptide epi- 
topes has now been determined to be only 8-10 residues 
[12], there is enough space for the peptide to move inside 
the groove, and polymorphic residues on the floor of the 
groove would guide the optimal positioning of the pep- 
Fig. 2. Stereoviews of the two binding orientations of an antigenic peptide (RYLENGKETLQ) inside the MHC groove: (A) complex 1and (B) 
complex 11. Only the terminal mino acids are labelled for clarity. The MHC backbone (Ca) is shown in red and the side chains in cyan. The antigenic 
peptide isshown in yellow. 
Fig. 3. Computer graphic picture of the strong hydrophobic stacking interactions of the principal tlchor residue inthe peptide antigen YI71 with 
residues F95, F 116, YI23 and F74 of H-2K d in complex II, Van der Waals dot surface highlights his festoon ofclosely intcracting aromatic residues, 
Strong hydrogen bonds between the backbone earbonyl of YI71 (peptidc) and the guanidyl group of R97 (H-2K") side chain arc also hown. 
Fig. 4. Stercovi0w showing the "elative positions of the peptides (cyan = complex I; yellow = complex !1) inside the H-2K '~ binding groove from 
the two ¢nergy-minimised complexes. The -,~ and ,r, helices forming the edges of the binding roove are enveloped in van der Waals dot surface. 
226 
Volume 303, number 2,3 FEBS LETTERS June 1992 
. . . . .  
Fig, 2. 
Fig. 3, 
Fig. 4. 
.°, 
• ' ~', i - " '  ;- ;~-"" .~ 
,+~--" ~5_y .... / ,. y:- 
A ': 
/" 
/ 
227 
Volume 303, number 2,3 FEBS LETTERS ,tune 1992 
tide inside it, However, a unique binding orientation or 
the antigenic peptides vis-a-vis the helix dipoles [22] of 
the ~ and ~x~ helices could be imposed by a hypothetical 
MHC-dependent protease [23] for processing longer 
peptides bound to MHC. 
4. CONCLUSIONS 
In summary, the peptide epitope HLA.A2.170-180 
presented by the mouse MHC H-2K d interacts better 
when the peptide is orientated with its amino-terminus 
at the righthand end of the MHC groove, guided by 
favourable hydrophobic and electrostatic interactions. 
An understanding of the general interaction pattern of 
several antigenic peptides in the binding grooves of their 
restriction MHC molecules could well help to design 
potent blocking peptide or peptidomimetic antigens. 
Also, the orientation of antigen presentation by MHC 
molecules could be allele-specific and perhaps governed 
by their sequence and structure. More detailed theoret- 
ical and experimental analysis on a variety of MHC- 
peptide complexes is required for confirmation .at" the 
models and such studies are in progress in our labora- 
tory. 
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